• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

41
19
18
17
17

COUNTRY

16
6
4
1
1

CATEGORIES

  • 76
  • 42
  • 17
  • 15
  • 12
  • 10
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

24
36
92
143

PUBLISHED

1
5
26
143

PRODUCT TYPE

136
6
1

Search "Biocon: Biosimilars Company Analysis" returned 143 results.

Biocon Limited - Product Pipeline Review - 2013

Biocon Limited - Product Pipeline Review - 2013 Summary “Biocon Limited - Product Pipeline Review - 2013” provides data on the Biocon Limited’s research and development focus. The report includes...

December 2013
FROM

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the...

July 2012
FROM

Biosimilars Market by Product & Application - Global Forecast to 2018

'Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application...

November 2013
FROM
Tapping Biosimilar Opportunities Tapping Biosimilar Opportunities - Product Thumbnail Image

Tapping Biosimilar Opportunities

Tapping biosimilar opportunities A Follow on biologic (FOB) or Biosimilar, as commonly known, has been one of the most widely discussed topics in the world of pharma in the last few years The approaching...

September 2011
FROM
India Biosimilar Market Analysis India Biosimilar Market Analysis - Product Thumbnail Image

India Biosimilar Market Analysis

As the number of patent expiries of biologic drugs is increasing, Indian companies are developing biosimilar manufacturing capabilities Firms are developing their capabilities by either forming partnerships...

August 2012
FROM

Global Cancer Biosimilars Market Opportunity Outlook

Cancer incidences are escalating tremendously across the globe due to which burgeoning pressure has been created on pharmaceutical companies to come forth with viable products. Moreover, presently available...

June 2015
FROM

The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

“The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways” provides insights on the biosimilars market revenues and growth until 2015 Further, the distribution...

December 2009
FROM

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production Summary GBI Research,...

June 2012
FROM
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

March 2014
FROM

Biocon Limited - Product Pipeline Review - 2014

Biocon Limited - Product Pipeline Review - 2014 Summary This, ‘Biocon Limited - Product Pipeline Review - 2014’, provides an overview of the Biocon Limited’s pharmaceutical research and development...

July 2014
FROM
Global Biosimilars Market - Products, Applications and Regulations Global Biosimilars Market - Products, Applications and Regulations - Product Thumbnail Image

Global Biosimilars Market - Products, Applications and Regulations

Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19 4bn by 2018 Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the...

November 2012
FROM

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH,...

September 2013
FROM

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence provider,...

April 2011
FROM
Biocon Limited - Product Pipeline Review - 2012 Biocon Limited - Product Pipeline Review - 2012 - Product Thumbnail Image

Biocon Limited - Product Pipeline Review - 2012

Biocon Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - 2012” provides data on the Biocon Limited’s research...

August 2012
FROM

Biosimilars - Global Strategic Business Report

This report analyzes the worldwide markets for Biosimilars in US$ Million The report provides separate comprehensive analytics for US, Europe, and Japan Annual estimates and forecasts are provided for...

April 2012
FROM
Biosimilar Index: Tracking the Global Biosimilar Pipeline Biosimilar Index: Tracking the Global Biosimilar Pipeline - Product Thumbnail Image

Biosimilar Index: Tracking the Global Biosimilar Pipeline

NOTE: The format of this Biosimilar Index is Excel & PowerPoint Biosimilar Index answers your questions, such as - There are 15 biosimilar and non-comparable biologic (NCB) versions of bevacizumab (Avastin;...

March 2014
Global Biosimilars Industry Global Biosimilars Industry - Product Thumbnail Image

Global Biosimilars Industry

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

October 2012
FROM
Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 - Product Thumbnail Image

Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020

Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon Patent expiration is the major driving factor of...

July 2014
FROM

Global Biosimilars Market 2014-2018

The analysts forecast the Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of...

February 2014
FROM

The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)

This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used...

September 2013
FROM
Loading Indicator

Our Clients

Ikea Systems B.V. GlaxoSmithKline PLC BT Group PLC. Philips N.V. BSH Home Appliances Ltd Foreign & Commonwealth Office